End-stage renal disease
Conditions
Interventions
None listed
Sponsors
Juntendo University Faculity of Medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients who had been started dialysis treatment from January 2018 to December 2020 in Juntendo University Hospital
Exclusion criteria
Exclusion criteria: The patients who had received a kidney transplant within 2 years after the initiation of dialysis treatment
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Alive or death three years after the initiation of dialysis | — |
Secondary
| Measure | Time frame |
|---|---|
| 1) Basic information; Age, Sex, Original disease, Medical history, Internal medicines 2) About the first visit; Date, What hospital or clinic did the patient visit before the first visit, CKD stage 3) About initiation of dialysis treatment; Date, Age, Hight, Body weight, Blood pressure, Blood test (BUN, Cre, eGFR, Hb, TSAT, ALB, Na, K, Ca, P, iPTH, HbA1c, Gly-A, TG, LDL-chol, HDL-chol, and CRP), Planned or emergency start of dialysis treatment, Chest X-ray findings, Ultrasonic cardiography findings 4) About the vascular access; Type, Date of operation, When the access had been used first, Vascular ultrasound findings before and after one week the operation 5) Medical fees when the patient hospitalized for initiation of dialysis treatment 6) Until 3 years after initiation of dialysis; History of hospitalization, vascular access troubles, disdialysis syndrome, Urine volume, EQ-5D score | — |
Countries
Japan
Contacts
Public ContactJunichiro Nakata
Juntendo University Faculity of Medicine Department of Nephrology
Outcome results
None listed